119 related articles for article (PubMed ID: 3305118)
1. Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease.
Bianchi Porro G; Lazzaroni M; Cortvriendt WR
Digestion; 1987; 37 Suppl 2():47-52. PubMed ID: 3305118
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment: colloidal bismuth subcitrate with H2-antagonists.
Salmon PR
Digestion; 1987; 37 Suppl 2():42-6. PubMed ID: 2887475
[TBL] [Abstract][Full Text] [Related]
3. A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers.
Ward M; Halliday C; Cowen AE
Digestion; 1986; 34(3):173-7. PubMed ID: 3530861
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
[TBL] [Abstract][Full Text] [Related]
5. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
Wilson P; Alp MH
Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
7. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
Lazzaroni M; Petrillo M; Bianchi Porro G
Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
[TBL] [Abstract][Full Text] [Related]
8. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers].
Hu FL; Jia BQ; Gao HZ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):339-41, 382. PubMed ID: 2269032
[TBL] [Abstract][Full Text] [Related]
10. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine.
Harley H; Alp MH
Med J Aust; 1983 Dec 10-24; 2(12):627-8. PubMed ID: 6366498
[TBL] [Abstract][Full Text] [Related]
12. The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.
Bianchi Porro B; Lazzaroni M; Parente F; Petrillo M
Scand J Gastroenterol Suppl; 1986; 122():35-8. PubMed ID: 3535020
[TBL] [Abstract][Full Text] [Related]
13. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results.
Bianchi Porro G; Parente F; Lazzaroni M; Pace F
Scand J Gastroenterol Suppl; 1986; 122():39-41. PubMed ID: 2877490
[TBL] [Abstract][Full Text] [Related]
14. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.
Vantrappen G; Rutgeerts P; Broeckaert L; Janssens J
Gut; 1980 Apr; 21(4):329-33. PubMed ID: 7000628
[TBL] [Abstract][Full Text] [Related]
15. Colloidal bismuth subcitrate as coated tablets: four times versus twice daily dosage in duodenal ulcer.
Lazzaroni M; Parente F; Prada A; Bianchi Porro G
Scand J Gastroenterol Suppl; 1986; 122():51-3. PubMed ID: 3535022
[TBL] [Abstract][Full Text] [Related]
16. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
Miller JP
Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
[TBL] [Abstract][Full Text] [Related]
17. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
18. An international multi-clinic study comparing the therapeutic efficacy of colloidal bismuth subcitrate coated tablets with chewing tablets in the treatment of duodenal ulceration.
Dekker W; Dal Monte PR; Bianchi Porro G; Van Bentem N; Boekhorst JC; Crowe JP; Robinson TJ; Thys O; Van Driel A
Scand J Gastroenterol Suppl; 1986; 122():46-50. PubMed ID: 3535021
[TBL] [Abstract][Full Text] [Related]
19. The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Barbara L; Corinaldesi R; Rea E; Paternicò A; Stanghellini V
Scand J Gastroenterol Suppl; 1986; 122():30-4. PubMed ID: 3535019
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
